MedTrace Logo

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

NCT05309460 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2024-04-12

No results posted yet for this study

Summary

Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.

Conditions

  • Postpartum Preeclampsia
  • Hypertension in Pregnancy

Interventions

DRUG

Labetalol Oral Tablet

See Labetalol arm.

DRUG

NIFEdipine ER

See Nifedipine arm.

Sponsors & Collaborators

  • Nebraska Methodist Health System

    lead OTHER

Principal Investigators

  • Todd Lovgren, MD · Nebraska Methodist Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-20
Primary Completion
2024-05-01
Completion
2024-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309460 on ClinicalTrials.gov